Main Line Patient Advocacy is categorized under Health Services in Ardmore, PA and active since 2012.
Main Line Patient Advocacy was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Mary Winterhalter at the company’s single location by writing to 18 West Ardmore Avenue, Ardmore, Pennsylvania PA 19003 or by phoning (610) 247-4784. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Main Line Patient Advocacy |
| Contact Person: | Mary Winterhalter |
| Address: | 18 West Ardmore Avenue, Ardmore, Pennsylvania 19003 |
| Phone Number: | (610) 247-4784 |
| Website Address: | mlpa.biz |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Main Line Patient Advocacy was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Mary Winterhalter for inquiries that concern Main Line Patient Advocacy by calling the company number (610) 247-4784, as your correspondence is most welcome. Additionally, the physical location of the single location of Main Line Patient Advocacy can be found at the coordinates 39.994159,-75.323466 as well as the street address 18 West Ardmore Avenue in Ardmore, Pennsylvania 19003.
For its online presence, you may visit Main Line Patient Advocacy’s website at mlpa.biz and engage with its social media outlets through on Twitter and on Facebook.